SK1342001A3 - Triazolopyridine, method and intermediates for the preparation thereof and pharmaceutical composition based thereon - Google Patents

Triazolopyridine, method and intermediates for the preparation thereof and pharmaceutical composition based thereon Download PDF

Info

Publication number
SK1342001A3
SK1342001A3 SK134-2001A SK1342001A SK1342001A3 SK 1342001 A3 SK1342001 A3 SK 1342001A3 SK 1342001 A SK1342001 A SK 1342001A SK 1342001 A3 SK1342001 A3 SK 1342001A3
Authority
SK
Slovakia
Prior art keywords
carbon atoms
alkyl
hydrogen
acid
amino
Prior art date
Application number
SK134-2001A
Other languages
English (en)
Slovak (sk)
Inventor
William J Hoekstra
Edward C Lawson
Bruce E Maryanoff
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of SK1342001A3 publication Critical patent/SK1342001A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
SK134-2001A 1998-07-27 1999-07-21 Triazolopyridine, method and intermediates for the preparation thereof and pharmaceutical composition based thereon SK1342001A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9423198P 1998-07-27 1998-07-27
US09/354,032 US6303625B1 (en) 1998-07-27 1999-07-15 Triazolopyridines for the treatment of thrombosis disorders
PCT/US1999/016572 WO2000006570A1 (en) 1998-07-27 1999-07-21 Triazolopyridines for the treatment of thrombosis disorders

Publications (1)

Publication Number Publication Date
SK1342001A3 true SK1342001A3 (en) 2002-04-04

Family

ID=22243910

Family Applications (1)

Application Number Title Priority Date Filing Date
SK134-2001A SK1342001A3 (en) 1998-07-27 1999-07-21 Triazolopyridine, method and intermediates for the preparation thereof and pharmaceutical composition based thereon

Country Status (21)

Country Link
US (1) US6303625B1 (pt)
EP (1) EP1102766B1 (pt)
JP (1) JP2003527306A (pt)
KR (1) KR20010079576A (pt)
CN (1) CN1320125A (pt)
AR (1) AR019477A1 (pt)
AT (1) ATE263169T1 (pt)
AU (1) AU757512B2 (pt)
BR (1) BR9912556A (pt)
CA (1) CA2338654A1 (pt)
CZ (1) CZ2001347A3 (pt)
DE (1) DE69916073T2 (pt)
ES (1) ES2219042T3 (pt)
HU (1) HUP0103832A3 (pt)
ID (1) ID27214A (pt)
MX (1) MXPA01001099A (pt)
NO (1) NO20010456L (pt)
PL (1) PL345769A1 (pt)
SK (1) SK1342001A3 (pt)
WO (1) WO2000006570A1 (pt)
ZA (1) ZA200100783B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306909B1 (en) 1997-03-12 2001-10-23 Queen's University At Kingston Anti-epileptogenic agents
CZ2002518A3 (cs) * 1999-08-13 2002-05-15 Biogen, Inc. Inhibitory buněčné adheze a farmaceutické prostředky, které je obsahují
TWI290136B (en) * 2000-04-05 2007-11-21 Daiichi Seiyaku Co Ethylenediamine derivatives
JP2004536071A (ja) * 2001-05-25 2004-12-02 クイーンズ ユニバーシティ アット キングストン 複素環ベータアミノ酸およびそれらの抗癲癇誘発剤としての使用
WO2003000657A1 (fr) 2001-06-20 2003-01-03 Daiichi Pharmaceutical Co., Ltd. Derives de diamine
WO2006018727A2 (en) * 2004-08-18 2006-02-23 Pharmacia & Upjohn Company Llc Triazolopyridine compounds useful for the treatment of inflammation
US7618983B2 (en) * 2004-11-10 2009-11-17 Janssen Pharmaceutica, N.V. Bicyclic triazole α4 integrin inhibitors
HUE029336T2 (en) * 2005-09-16 2017-02-28 Daiichi Sankyo Co Ltd For the preparation of an optically active diamine derivative and process
WO2008045393A2 (en) * 2006-10-11 2008-04-17 Amgen Inc. Imidazo- and triazolo-pyridine compounds and methods of use therof
EP2417135A1 (en) * 2009-04-07 2012-02-15 Schering Corporation Substituted triazolopyridines and analogs thereof
US8871760B2 (en) * 2009-09-21 2014-10-28 Roche Palo Alto Llc [1,2,4]triazolo[3,4-C][1,4]oxazines as P2X7 modulators
MX339302B (es) 2011-09-15 2016-05-19 Novartis Ag 3-(quinolin-6-il-tio)-[1,2,4]-triazolo-[4,3-a]-piridinas 6-sustituidas como cinasas de tirosina.
EP3004095A1 (de) * 2013-06-03 2016-04-13 Bayer Pharma Aktiengesellschaft Triazolopyridine als thrombininhibitoren zur behandlung von thromboembolischen erkrankungen
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3050525A (en) 1960-12-14 1962-08-21 John B Bicking Certain derivatives of s-triazolo [4, 3-a]-pyridine
NZ262664A (en) 1993-02-22 1997-04-24 Merck & Co Inc Heterocyclic substituted derivatives, and medicaments thereof
DE4326758A1 (de) * 1993-08-10 1995-02-16 Basf Ag [1,3,4]Triazolo[1,5-a]pyridine
CA2134192A1 (en) 1993-11-12 1995-05-13 Michael L. Denney 5, 6-bicyclic glycoprotein iib/iiia antagonists

Also Published As

Publication number Publication date
JP2003527306A (ja) 2003-09-16
EP1102766A1 (en) 2001-05-30
WO2000006570A1 (en) 2000-02-10
ES2219042T3 (es) 2004-11-16
AU5221899A (en) 2000-02-21
PL345769A1 (en) 2002-01-02
HUP0103832A3 (en) 2002-12-28
CZ2001347A3 (cs) 2001-12-12
HUP0103832A2 (hu) 2002-04-29
US6303625B1 (en) 2001-10-16
ZA200100783B (en) 2002-01-28
NO20010456D0 (no) 2001-01-26
ID27214A (id) 2001-03-08
DE69916073D1 (de) 2004-05-06
NO20010456L (no) 2001-03-26
CN1320125A (zh) 2001-10-31
DE69916073T2 (de) 2004-12-30
CA2338654A1 (en) 2000-02-10
AR019477A1 (es) 2002-02-20
AU757512B2 (en) 2003-02-20
ATE263169T1 (de) 2004-04-15
MXPA01001099A (es) 2002-04-24
EP1102766B1 (en) 2004-03-31
KR20010079576A (ko) 2001-08-22
BR9912556A (pt) 2002-01-15

Similar Documents

Publication Publication Date Title
US6069254A (en) Carboxamide derivatives of piperidine for the treatment of thrombosis disorders
US6303625B1 (en) Triazolopyridines for the treatment of thrombosis disorders
AU703397B2 (en) Nipecotic acid derivatives as antithrombic compounds
US6191145B1 (en) Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders
EP1133489B9 (en) Isonipecotamides for the treatment of integrin-mediated disorders
MXPA00004201A (en) Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders
MXPA01005347A (en) Isonipecotamides for the treatment of integrinmediated disorders
EP1533310A1 (en) Isonipecotamides for the treatment of integrin-mediated disorders
EP1184374A1 (en) Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders